1. Seasonal Influenza Therapeutics in Asia- Pacific Markets to 2022-Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

2. Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022-Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza. Request a sample of this report @ http://www.orbisresearch.com/contacts/request- sample/193032.http://www.orbisresearch.com/contacts/request- sample/193032 Seasonal influenza vaccines comprises a high number of vaccines in early-stage development, many of which are new formulations or those that have been developed using the cell culture method. Late-stage vaccines are either quadrivalent vaccines or pediatric versions of those that have already been approved. GBI Research expects that quadrivalent seasonal influenza vaccines will replace their trivalent vaccines forerunner by the end of the forecast period. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

3. About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022-Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies